These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28628199)

  • 1. Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.
    Niepel M; Hafner M; Chung M; Sorger PK
    Curr Protoc Chem Biol; 2017 Jun; 9(2):55-74. PubMed ID: 28628199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.
    Hafner M; Niepel M; Chung M; Sorger PK
    Nat Methods; 2016 Jun; 13(6):521-7. PubMed ID: 27135972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
    Yakisich JS; Venkatadri R; Azad N; Iyer AKV
    J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics.
    Hafner M; Heiser LM; Williams EH; Niepel M; Wang NJ; Korkola JE; Gray JW; Sorger PK
    Sci Data; 2017 Nov; 4():170166. PubMed ID: 29112189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AutoDiSC: development and validation of a novel chemotherapy sensitivity and resistance assay.
    Schinköthe T; Thiruchittampalam D; Schmidt A; Bomholt N; Staib P
    Anticancer Res; 2013 Jun; 33(6):2491-8. PubMed ID: 23749900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
    Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T
    Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
    Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
    PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
    Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.
    Bai J; Wang RH; Qiao Y; Wang A; Fang CJ
    Drug Des Devel Ther; 2017; 11():2227-2237. PubMed ID: 28814831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging.
    Luo Z; Samadzadeh KM; Nitin N
    Anal Biochem; 2016 Jul; 504():50-8. PubMed ID: 27059751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library Screens.
    Tomska K; Scheinost S; Zenz T
    Methods Mol Biol; 2019; 1956():351-362. PubMed ID: 30779044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate.
    Stevens MM; Maire CL; Chou N; Murakami MA; Knoff DS; Kikuchi Y; Kimmerling RJ; Liu H; Haidar S; Calistri NL; Cermak N; Olcum S; Cordero NA; Idbaih A; Wen PY; Weinstock DM; Ligon KL; Manalis SR
    Nat Biotechnol; 2016 Nov; 34(11):1161-1167. PubMed ID: 27723727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
    Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
    Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate stiffness influences the outcome of antitumor drug screening in vitro.
    Feng J; Tang Y; Xu Y; Sun Q; Liao F; Han D
    Clin Hemorheol Microcirc; 2013; 55(1):121-31. PubMed ID: 23445634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of ornithine decarboxylase as a measure of chemosensitivity testing.
    Bachrach U
    Methods Mol Med; 2005; 110():197-211. PubMed ID: 15901937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens.
    Larsson P; Engqvist H; Biermann J; Werner Rönnerman E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K; Parris TZ
    Sci Rep; 2020 Apr; 10(1):5798. PubMed ID: 32242081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants.
    Yang J; Chen K; Zhang G; Yang QY; Li YS; Huang SZ; Wang YL; Yang W; Jiang XJ; Yan HX; Zhu JQ; Xiang R; Luo YF; Li WM; Wei YQ; Li LL; Yang SY
    Eur J Med Chem; 2018 Jan; 143():1148-1164. PubMed ID: 29133048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.